| P/E (FY) | — | Sales (TTM) | $18.9M |
| Earnings (TTM) | -$21.1M | ROE | — |
| Net Margin | −111.40% | ROIC | −130.66% |
| Debt / Equity | 1.57 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $31.9M | Trading Days | 382 |
| 52W High | 7.60 |
| 52W Low | 2.64 |
| % Off High | −65.13% |
| YTD | −70.56% | 1Y | −55.76% |
| Since incept. (ann.) | −57.21% |
Reportable 100%
| Ann. Volatility (1Y) | 78.66% | Ann. Volatility (3Y) | 129.09% |
| Sharpe (1Y) | −1.87 | Sharpe (3Y) | −0.42 |
| Max Drawdown (1Y) | −65.09% | Max Drawdown (3Y) | −87.38% |
| Beta (3Y, vs SPY) | −1.03 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| VASO | VASO Corp | $33.4M | 19.0 |
| POCI | PRECISION OPTICS CORPORATION, INC. | $48.6M | — |
| ECOR | electroCore, Inc. | $50.5M | — |
| IRIX | IRIDEX CORP | $15.3M | — |
| HYPR | Hyperfine, Inc. | $74.9M | — |
| STEX | Streamex Corp. | $76.9M | — |
| NRXS | Neuraxis, INC | $80.9M | — |
| OM | Outset Medical, Inc. | $87.5M | — |
| VANI | Vivani Medical, Inc. | $113.0M | — |
| STXS | Stereotaxis, Inc. | $125.1M | — |
| NXL | Nexalin Technology, Inc. | $6.9M | — |
| NDRA |
| ENDRA Life Sciences Inc. |
| $5.7M |
| — |
